Allergic Asthma
📧 Sign up to get email alerts when something new happens for Allergic Asthma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-12-11Clinical Trial Update: Predicting the Clinical Response to Omalizumab With Anti-Immunoglobulin E (IgE) Ab Response or Syk Expression in Basophils [Phase 4]
Phase 4 trial assessed whether basophil biomarker responses (anti-IgE antibodies or Syk expression) can predict how patients with allergic a…
-
CLINICAL_TRIALS trial_result · 2017-04-07Clinical Trial Update: Cobra (Severe Asthma)Medical-economic
The Cobra trial evaluating a treatment for allergic asthma with severe features has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-18Clinical Trial Update: Long-term Safety, Tolerability and Efficacy of Omalizumab in Japanese Children [Phase 3]
This update presents long-term safety, tolerability, and efficacy data for omalizumab in Japanese children with allergic asthma from a Phase…
-
CLINICAL_TRIALS trial_result · 2016-10-25Clinical Trial Update: A Study to Evaluate the Effect of Roflumilast on Airway Inflammation and Function Following Allergen Challenge in Subjects With Allergic Asthma [Phase 2]
Phase 2 study evaluating the effect of roflumilast on airway inflammation and function after allergen challenge in subjects with allergic as…
-
CLINICAL_TRIALS trial_result · 2016-08-08Clinical Trial Update: The Effect of Salmeterol on Eosinophil (EOS) Function [NA]
This clinical trial update assesses how salmeterol affects eosinophil function in allergic asthma. The study is complete, with results poste…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: A Study Evaluating the Efficacy of QGE031 Compared to Omalizumab in Patients With Allergic Asthma [Phase 1, Phase 2]
A completed Phase 1/2 study evaluating the efficacy of QGE031 compared with omalizumab in patients with allergic asthma.
-
CLINICAL_TRIALS trial_result · 2016-01-26Clinical Trial Update: The Tolerability and Effects of AZD8848 in Allergic Asthma Subjects Challenged With Inhaled Allergen [Phase 2]
Phase 2 trial evaluating tolerability and effects of AZD8848 in subjects with allergic asthma; the study has completed and results have been…
-
CLINICAL_TRIALS trial_result · 2015-12-22Clinical Trial Update: Safety and Efficacy Study of Omalizumab to Treat Allergic Asthma [Phase 2, Phase 3]
A clinical trial update evaluating the safety and efficacy of omalizumab for allergic asthma across Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2015-10-29Clinical Trial Update: The Effect of Allergen Immunotherapy on Exhaled Nitric Oxide in Adult Patients With Asthma and Allergic Rhinitis
A completed clinical trial assessed the effect of allergen immunotherapy on exhaled nitric oxide in adults with allergic asthma and allergic…
-
CLINICAL_TRIALS trial_result · 2015-09-15Clinical Trial Update: Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing
A completed pharmacosurveillance trial evaluating Xolair (omalizumab) dosing in patients with and without a history of anaphylactic reaction…
-
CLINICAL_TRIALS trial_result · 2015-09-07Clinical Trial Update: Efficacy Of Bacterial Lysate In Asthmatic Children [Phase 3]
Phase 3 trial evaluating the efficacy of a bacterial lysate in children with allergic asthma has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-09Clinical Trial Update: Change in Airway Responsiveness After Allergen Exposure [NA]
This update reports the completion of a study evaluating changes in airway responsiveness after allergen exposure in individuals with allerg…
-
CLINICAL_TRIALS trial_result · 2015-03-27Clinical Trial Update: Validation of Proteomic Analyses for Allergic Asthma and Rhinitis
This completed clinical trial assesses proteomic analyses in allergic asthma and allergic rhinitis.
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: Extracorporeal SPecific IgE Removal From the Plasma of Allergic Asthma Patients (ESPIRA-study) [NA]
The ESPIRA study, which evaluated extracorporeal removal of specific IgE from plasma in allergic asthma patients, has completed.
-
CLINICAL_TRIALS trial_result · 2014-12-30Clinical Trial Update: A Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Subjects With IgE >= 30 IU/mL [Phase 1]
Phase 1 randomized, placebo-controlled, dose-escalation safety study of MEDI4212 in subjects with IgE ≥ 30 IU/mL has completed and results h…
-
CLINICAL_TRIALS trial_result · 2014-11-13Clinical Trial Update: 2nd Pivotal Study rPhleum - Adults and Adolescents With Rhinoconjunctivitis +/-Controlled Asthma [Phase 3]
A Phase 3 pivotal trial of recombinant Timothy grass allergen (rPhleum) in adults and adolescents with rhinoconjunctivitis with or without c…
-
CLINICAL_TRIALS trial_result · 2014-10-15Clinical Trial Update: A Study Evaluating the Persistency of Response With or Without Xolair (Omalizumab) After Long-term Therapy [Phase 4]
Phase 4 study evaluating the persistence of response after long-term omalizumab therapy in allergic asthma, comparing continued treatment wi…
-
CLINICAL_TRIALS trial_result · 2014-08-12Clinical Trial Update: The Role of Th9 Cells and Eosinophils Activity in Allergic Airway Diseases
A clinical trial update examines the role of TH9 cells and eosinophil activity in allergic airway diseases, including allergic asthma and al…
-
CLINICAL_TRIALS trial_result · 2014-05-14Clinical Trial Update: CYT003-QbG10, a TLR9-agonist, for Treatment of Uncontrolled Moderate to Severe Allergic Asthma [Phase 2]
This update reports the termination of a Phase 2 study of CYT003-QbG10, a TLR9 agonist, for treatment of uncontrolled moderate to severe all…
-
CLINICAL_TRIALS trial_result · 2013-11-20Clinical Trial Update: Study to Evaluate the Safety and Efficacy TPI ASM8 in Subjects With Asthma [Phase 2]
A Phase 2 study evaluating the safety and efficacy of TPI ASM8 in allergic asthma has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonists [Phase 4]
Phase 4 trial results evaluate the efficacy of omalizumab in adults aged 18-60 with moderate-to-severe persistent allergic asthma who remain…
-
CLINICAL_TRIALS trial_result · 2012-08-15Clinical Trial Update: Optimization of Asthma Treatment Through Exhaled NO for Increased Asthma-Related Quality of Life (NOAK) [NA]
This entry notes the completion of a trial studying exhaled nitric oxide-guided asthma treatment (NOAK) for allergic asthma. The sponsor is …
-
CLINICAL_TRIALS trial_result · 2012-01-19Clinical Trial Update: Utility of Versican and Hyaluronan Measurement in Induced Sputum as Biomarkers of Asthma [Phase 4]
This Phase 4 clinical trial evaluated whether measuring versican and hyaluronan in induced sputum can serve as biomarkers for asthma.
-
CLINICAL_TRIALS trial_result · 2011-11-24Clinical Trial Update: Induction of Allergen Specific Bronchial Immunotolerance After Specific Immunotherapy
This completed clinical trial evaluated whether induction of allergen-specific bronchial immunotolerance can be achieved after specific immu…
-
CLINICAL_TRIALS trial_result · 2011-10-12Clinical Trial Update: Safety and Repeatability of Bronchial Challenge With Grass-pollen
This clinical trial update assesses the safety and repeatability of performing bronchial challenges with grass pollen in individuals with al…